Statistics

Total Visits

Views
Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks75

File Visits

Downloads
39254-976.pdf17

Select a period of time:

Number of views in the range

Views
Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks21

Number of downloads in the range

Downloads

Views

Views
June 20250
July 202511
August 20250
September 20258
October 20252
November 20250
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil8
United States6
United Kingdom3
Colombia1
Costa Rica1
Dominican Republic1
Paraguay1
 

Top cities views

Views
Dallas2
Bogotá1
Caruaru1
Fontana1
Iramaia Municipality1
Leeds1
Memphis1
Peruíbe1
Ribeirão Preto1
Rio de Janeiro1